Finance

Lists
Why is IBO up 2,18%?
Dive Deeper
IBO:NYSEAMERICAN
Impact Biomedical Inc
4,21 USD
+2,18%
(+0,090) 1D
9-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBO...
Open
4,13 USD
High
4,39 USD
Low
4,13 USD
Mkt. cap
35,97 млн
Volume
4,02 миң
52-wk high
10,47 USD
52-wk low
4,06 USD
EPS
-1,13 USD
Shares outstanding
8,54 млн
No. of employees
2
Open
4,13 USD
High
4,39 USD
Low
4,13 USD
Mkt. cap
35,97 млн
Volume
4,02 миң
52-wk high
10,47 USD
52-wk low
4,06 USD
EPS
-1,13 USD
Shares outstanding
8,54 млн
No. of employees
2
News stories
From web sources and news partners
About Impact Biomedical Inc
CEO-
Employees2
Founded2018
HeadquartersХьюстон, Техас, Америка Кошмо Штаттары
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
18,00 миң
7,00 миң
7,00 миң
3,00 миң
Cost of goods sold
1,00 миң
422,00 миң
-
1,00 миң
Cost of revenue
1,00 миң
422,00 миң
-
1,00 миң
Research and development expenses
52,00 миң
110,00 миң
46,00 миң
76,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
516,00 миң
275,00 миң
1,90 млн
277,00 миң
Operating expense
965,00 миң
743,00 миң
2,30 млн
704,00 миң
Total operating expenses
966,00 миң
1,16 млн
2,30 млн
705,00 миң
Operating income
-948,00 миң
-1,16 млн
-2,29 млн
-702,00 миң
Other non operating income
-268,00 миң
3,82 млн
-
-
EBT including unusual items
-1,48 млн
2,66 млн
-2,28 млн
-700,00 миң
EBT excluding unusual items
-1,48 млн
2,67 млн
-2,28 млн
-700,00 миң
Income tax expense
-
-2,58 млн
-
-
Effective tax rate
-
-97,18%
-
-
Other operating expenses
109,00 миң
72,00 миң
67,00 миң
67,00 миң
Net income
-1,47 млн
5,24 млн
-2,29 млн
-699,00 миң
Net profit margin
-8 166,67%
74 928,57%
-32 671,43%
-23 300,00%
Earnings per share
-
-
-
-
Interest and investment income
3,00 миң
3,00 миң
5,00 миң
2,00 миң
Interest expense
-262,00 миң
-
-
-
Net interest expenses
-259,00 миң
3,00 миң
5,00 миң
2,00 миң
Depreciation and amortization charges
288,00 миң
286,00 миң
285,00 миң
284,00 миң
EBITDA
-92,00 миң
-872,00 миң
-2,00 млн
-418,00 миң
Gain or loss from assets sale
-
12,00 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору